KPV KP5 5mg*10vials

KPV KP5 5mg*10 vials (lysine-proline-valine) is a high-purity, bioactive anti-inflammatory regulatory peptide, belonging to the repair peptide series. As the classic standard specification of the KPV peptide series, it is a bioactive short-chain tripeptide fragment derived from endogenous α-MSH molecules, possessing extremely high biocompatibility, zero immunogenicity, and excellent biochemical stability. Unlike traditional repair peptides, KPV focuses on targeting and inhibiting inflammation, maintaining immune homeostasis, alleviating neuroinflammation, and stabilizing the barrier microenvironment. The standardized 5mg concentration can stably and effectively inhibit inflammatory signals without causing excessive physiological intervention. It is highly suitable for routine preclinical studies such as intervention in chronic inflammation models, skin barrier inflammation regulation and repair, neuroinflammatory microenvironment regulation, and synergistic immunomodulation of peptide complexes. It is a core standard research material for the study of inflammatory pharmacology and immunomodulatory mechanisms.

Product Functions and Research Value

In systematic laboratory studies, KPV KP5 5mg can precisely target and inhibit overactivated inflammatory signaling pathways, stably regulate immune cell activity, and block the release of various pro-inflammatory factors. Its core research functions and advantages encompass four key dimensions: effectively inhibiting persistent chronic inflammatory responses, repairing inflammatory damage to the skin and mucous membrane barriers, alleviating neuroinflammation and optimizing the neural microenvironment, and stabilizing systemic immune homeostasis to prevent cytokine storms. As a highly effective anti-inflammatory peptide validated by multiple biomedical studies, KPV effectively improves abnormal inflammatory phenotypes such as skin redness, swelling, and itching, and has significant regulatory effects on refractory superficial inflammatory models, including dermatitis and mild psoriasis. Simultaneously, it inhibits excessive activation of glial cells, reduces secondary neuroinflammatory damage, and protects the physiological stability of nerve tissue. The 5mg classic balanced formulation offers mild, stable, and highly reproducible biological activity, making it ideal for long-term, sustained inflammatory interventions, validation of basic immune mechanisms, and research on the synergistic anti-inflammatory effects of complex peptides. It provides standardized, authoritative, and stable experimental data for basic and applied research in inflammatory pathology, neuroimmunology, and barrier repair pharmacology.

Core Product Advantages

1. Endogenous High-Safety Ternary Structure: Derived from natural endogenous active fragments, it possesses extremely high biocompatibility, zero immune rejection, mild and non-irritating physiological activity, and excellent experimental safety.

2. Precisely Targeted Anti-inflammatory Mechanism: Unlike broad-spectrum repair, KPV focuses on inhibiting core inflammatory pathways, specifically improving the risk of chronic low-grade inflammation and barrier inflammation damage, filling a technological gap in the research of inflammatory peptide regulatory peptides.

3. Dual Skin and Neuroinflammatory Regulatory Efficacy: Integrating the dual effects of skin barrier inflammation repair and neuroinflammatory stabilization, it covers research scenarios of skin inflammation intervention and dual regulation of the neural microenvironment, with broad academic application prospects.

4. High-Stability Purification and Lyophilization Process: Employing multi-level gradient deep purification and vacuum lyophilization locking technology, it completely preserves the active structure, with zero impurities and foreign protein interference, ultra-pure experimental variables, and accurate and reliable research conclusions.

5. Standard Aseptic Integrated Packaging: 10 bottles integrated dust-free and aseptic packaging; each batch of product undergoes rigorous HPLC purity testing and is accompanied by a complete official COA certificate. This product exhibits long-term stable activity retention, making it widely applicable to basic research in university laboratories, preclinical studies in inflammatory pharmacology, and global bulk wholesale procurement.

KPV KP5 5mg*10 vials (lysine-proline-valine) belongs to the repair peptide class and is the **classic basic standard specification** of the KPV anti-inflammatory regulatory peptide series. This product is a short-chain tripeptide modified from an endogenous α-MSH active fragment, possessing excellent biocompatibility, zero immunogenicity, and stable biochemical properties. Unlike traditional repair peptides that focus on tissue regeneration, KPV's core positioning is **targeted anti-inflammatory, immune homeostasis regulation, and neuroinflammation**.